○ Specialty Care Unit : 10/2023 - 04/2024• Assigned to execute strategic marketing plans for 5 neuropsychiatry brands: Zomac (Eszopiclone), Sedoxil (Mexazolam), resulting in a 30% increase in brand visibility.• GTM strategy for Temazleep (Temazepam) launch in the UAE market, March 2024.• Active participation in 20 regional conferences, increasing brand awareness with 4000 health care professionals- 2023.○ Primary Care Unit : 01/2023- 09/2023• Developed S&E project with major UAE chain pharmacies (Aster, Life & Bin Sina & Al Thiqa), growing sales +70% compared to 2022.

My job responsibilities : Determine and dispense medicationAdvise medical teams on medication and dosagesProvide clinical pharmacy services and medication reconciliationCounsel patients on medication use

○ Primary Care Unit • Outperforming OTC line (Provita Vitamin D range, Provita Multivitamins, Otosan nasal sprays ) with achievement 105% in 2020.• Leading 10 Vitamin D test campaign during COVID-19 in 5 medical centers for 400 enrolled patient in, 2020-2021.• Growing and extending Provita vitamin D range in big hospitals, exceeded sales target by 115% in 2021.• Maintaining growth by 40% on annual basis for Vitamin D range (kids/adults) in 2022.

◘ DCV (DIABETES CARDIOVASCULAR BUSINESS UNIT)• Managed insulin portfolio: Lantus ®/ Toujeo ® (Insulin Glargine) Apidra ® (Insulin Glulisine) in both Private and MOH sectors .◘Achievements:○ Best practice : Toujeo launch in MOH• Toujeo's fastest inclusion into MOH’s diabetes centers, 2018.○ Best practice : Toujeo launch in retail• Won the tender from Umelkora University hitting the 300% sales achievement on Toujeo, 2017.○ Top performer : Sanofi DCV team• Achieving 115% & 80% delta growth in the hospital insulin market, 2015.◘ Assignments:○ MOH Proinsulin Project • Coordinating the strategic partnership of Sanofi with the Saudi Ministry of health in the western region for insulin awareness, 2018. ○ L&DG “Learning & Development Group” • Led 2 waves involved 53 sessions for the preparation to Sanofi's talent pool assessment. Awarded the best Sanofi initiative ,2018- 2019.○ SDF “Sanofi Diabetes Forum” • Standalones coordinator in Makkah, 2014-2019.

○ Managing diabetes line Galvus (Vildagliptin)• Achieved 95% in 2013 sales target.• +20% delta growth over OADs market.